Found: 3908
Select item for more details and to access through your institution.
Presence of focal usual interstitial pneumonia is a key prognostic factor in progressive pulmonary fibrosis.
- Published in:
- Histopathology, 2024, v. 85, n. 1, p. 104, doi. 10.1111/his.15179
- By:
- Publication type:
- Article
Therapeutic Strategies for Idiopathic Pulmonary Fibrosis – Thriving Present and Promising Tomorrow.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 7, p. 779, doi. 10.1002/jcph.2408
- By:
- Publication type:
- Article
Surgical lung biopsy for Idiopathic Pulmonary Fibrosis: Is the risk–benefit ratio changing.
- Published in:
- Respirology, 2024, v. 29, n. 7, p. 533, doi. 10.1111/resp.14719
- By:
- Publication type:
- Article
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest.
- Published in:
- Respirology, 2024, v. 29, n. 7, p. 545, doi. 10.1111/resp.14757
- By:
- Publication type:
- Article
Global challenges and disparities of care for interstitial lung disease.
- Published in:
- Respirology, 2024, v. 29, n. 7, p. 548, doi. 10.1111/resp.14766
- By:
- Publication type:
- Article
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort.
- Published in:
- Respirology, 2024, v. 29, n. 7, p. 596, doi. 10.1111/resp.14695
- By:
- Publication type:
- Article
The impact of antifibrotic use on long-term clinical outcomes in the pulmonary fibrosis foundation registry.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02883-2
- By:
- Publication type:
- Article
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02875-2
- By:
- Publication type:
- Article
Treating sleep-disordered breathing of idiopathic pulmonary fibrosis patients with CPAP and nocturnal oxygen treatment. A pilot study: Sleep-disordered breathing treatment in IPF.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.
- Published in:
- Stem Cell Research & Therapy, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13287-024-03782-5
- By:
- Publication type:
- Article
Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02878-z
- By:
- Publication type:
- Article
Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in mice.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64548-w
- By:
- Publication type:
- Article
Tolerability and efficacy of switching anti-fibrotic treatment from nintedanib to pirfenidone for idiopathic pulmonary fibrosis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0305429
- By:
- Publication type:
- Article
IPF-related new macrophage subpopulations and diagnostic biomarker identification - combine machine learning with single-cell analysis.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02845-8
- By:
- Publication type:
- Article
Clinical, radiological and histopathological features of patients with familial pulmonary fibrosis.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02864-5
- By:
- Publication type:
- Article
Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1256649
- By:
- Publication type:
- Article
Stress–strain curve and elastic behavior of the fibrotic lung with usual interstitial pneumonia pattern during protective mechanical ventilation.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63670-z
- By:
- Publication type:
- Article
Dual Barrier‐Penetrating Inhaled Nanoparticles for Enhanced Idiopathic Pulmonary Fibrosis Therapy.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 23, p. 1, doi. 10.1002/adfm.202315128
- By:
- Publication type:
- Article
Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 01, doi. 10.3389/fcimb.2024.1348685
- By:
- Publication type:
- Article
Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03081-y
- By:
- Publication type:
- Article
The Impact of Integrated Palliative Care on Survival in Idiopathic Pulmonary Fibrosis: A Retrospective Multicenter Comparison.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2024, v. 41, n. 6, p. 610, doi. 10.1177/10499091231194722
- By:
- Publication type:
- Article
A Test to Comprehensively Capture the Known Genetic Component of Familial Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2024, v. 70, n. 6, p. 437, doi. 10.1165/rcmb.2024-0009MA
- By:
- Publication type:
- Article
Inhibition of Distal Glycolytic Enzymes Suppresses Fibroblast Activation without Deleterious Bioenergetic Effects.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2024, v. 70, n. 6, p. 519, doi. 10.1165/rcmb.2023-0193LE
- By:
- Publication type:
- Article
Idiopathic Pulmonary Fibrosis Incidentally Detected by Computed Tomography Scan as Interstitial Lung Abnormalities.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 6, p. 983, doi. 10.1513/AnnalsATS.202310-850RL
- By:
- Publication type:
- Article
Cell-Based Therapy for Fibrosing Interstitial Lung Diseases, Current Status, and Potential Applications of iPSC-Derived Cells.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 11, p. 893, doi. 10.3390/cells13110893
- By:
- Publication type:
- Article
CTHRC1: An Emerging Hallmark of Pathogenic Fibroblasts in Lung Fibrosis.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 11, p. 946, doi. 10.3390/cells13110946
- By:
- Publication type:
- Article
Comparative Pharmacokinetics and Safety Assessment of 1st‐ and 2nd‐Generation Zinpentraxin Alfa Drug Products in Healthy Volunteers: A Randomized Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 655, doi. 10.1002/cpdd.1403
- By:
- Publication type:
- Article
A Commentary on the Role of Pulmonary Function Parameters in Idiopathic Pulmonary Fibrosis Follow‐Up.
- Published in:
- Clinical Respiratory Journal, 2024, v. 18, n. 6, p. 1, doi. 10.1111/crj.13797
- By:
- Publication type:
- Article
Clinical features analysis and treatment of systemic lupus erythematosus related interstitial lung disease.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 6, p. 1, doi. 10.1111/1756-185X.15226
- By:
- Publication type:
- Article
Pursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry.
- Published in:
- Lung, 2024, v. 202, n. 3, p. 269, doi. 10.1007/s00408-024-00694-2
- By:
- Publication type:
- Article
Commentary: Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: A Two‑Sample Mendelian Randomization Study.
- Published in:
- Lung, 2024, v. 202, n. 3, p. 357, doi. 10.1007/s00408-024-00687-1
- By:
- Publication type:
- Article
Authors' Reply to Letter to the Editor Regarding the Article "Genetic Association of Circulating Adipokines with Risk of Idiopathic Pulmonary Fibrosis: a Two-Sample Mendelian Randomization Study".
- Published in:
- Lung, 2024, v. 202, n. 3, p. 361, doi. 10.1007/s00408-024-00688-0
- By:
- Publication type:
- Article
The Rationale, Evidence, and Adaptations to Pulmonary Rehabilitation for Chronic Respiratory Diseases Other Than COPD.
- Published in:
- Respiratory Care, 2024, v. 69, n. 6, p. 697, doi. 10.4187/respcare.12089
- By:
- Publication type:
- Article
Impact of emphysema on mortality in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
- Published in:
- European Journal of Inflammation, 2024, p. 1, doi. 10.1177/1721727X241258923
- By:
- Publication type:
- Article
Experiences of living with idiopathic pulmonary fibrosis in relation to physical activity - "How the hills became steeper and steeper": a qualitative interview study.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03064-z
- By:
- Publication type:
- Article
Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03021-w
- By:
- Publication type:
- Article
Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02848-5
- By:
- Publication type:
- Article
Human Muse cells isolated from preterm- and term-umbilical cord delivered therapeutic effects in rat bleomycin-induced lung injury model without immunosuppressant.
- Published in:
- Stem Cell Research & Therapy, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13287-024-03763-8
- By:
- Publication type:
- Article
Interstitial Lung Disease: A Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 19, p. 1655, doi. 10.1001/jama.2024.3669
- By:
- Publication type:
- Article
Lactate facilitated mitochondrial fission-derived ROS to promote pulmonary fibrosis via ERK/DRP-1 signaling.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05289-2
- By:
- Publication type:
- Article
Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2024, p. 1, doi. 10.1177/17534666241250332
- By:
- Publication type:
- Article
Initial results with [<sup>18</sup>F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 6, p. 1605, doi. 10.1007/s00259-023-06564-y
- By:
- Publication type:
- Article
Impact of Controlling Nutritional Status Score on Mortality in Elderly Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 2825, doi. 10.3390/jcm13102825
- By:
- Publication type:
- Article
MicroRNA-26a in respiratory diseases: mechanisms and therapeutic potential.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09576-5
- By:
- Publication type:
- Article
Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02825-y
- By:
- Publication type:
- Article
Changes in physical activity in people with idiopathic pulmonary fibrosis before and after virtual pulmonary rehabilitation: a feasibility study.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03030-9
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00264-0
- By:
- Publication type:
- Article
Do Ultrafine Particles Carry Any Weight When It Comes to Progression of Pulmonary Fibrosis?
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1050, doi. 10.1164/rccm.202312-2368ED
- By:
- Publication type:
- Article
Looking Beyond the Lower Airways for Microbes Affecting Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1054, doi. 10.1164/rccm.202312-2255ED
- By:
- Publication type:
- Article
Gazing into the Proteomic Crystal Ball: Predicting Survival in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1056, doi. 10.1164/rccm.202311-2108ED
- By:
- Publication type:
- Article